Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × ALT-803 × Gastrointestinal × Clear all

Phase

Status

Terminated 6 Withdrawn 2 Completed 2 Active not recruiting 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Thoracic 1 Sarcoma 1 Lymphoid 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 88 Bevacizumab 67 Capecitabine 66 Fluorouracil 46 Drug Therapy 42 tislelizumab 41 Gemcitabine 40 Leucovorin 37 sintilimab 36 Irinotecan 31 lenvatinib 30 Cisplatin 25 Immune Checkpoint Inhibitors 24 S 1 (combination) 23 HMPL-013 23 camrelizumab 21 Radiotherapy 20 130-nm albumin-bound paclitaxel 19 toripalimab 18 irinotecan sucrosofate 18 apatinib 18 Surgical Procedures, Operative 18 Paclitaxel 18 Radiosurgery 17 Injections 16 Folfox protocol 15 pembrolizumab 14 Immunotherapy 14 Cetuximab 13 trifluridine tipiracil drug combination 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07488884 2026-03-23

ResQ108B-PANC

ImmunityBio, Inc.

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡